teva pharmaceuticals introduces the first generic glp-1 for weight loss Did you hear huge news? π, We now have a medication! What does this mean you for? This will increase access to medications, making it easier you to hit your weight Teva Claims A First With
Description
Wharton S., Blevins T., Connery L., et al., Daily Oral GLP1 Receptor Agonist Orforglipron for Adults With Obesity, New England Journal of Medicine 389 (2023): 877888

20, 2024, the FDA approved tirzepatide (Zepbound) for the treatment of moderate-to-severe OSA in adults with obesity, with and without positive airway pressure (PAP) therapy, making it the first GLP-1 indicated for OSA

The study used the Massachusetts General Hospital-Sexual Functioning Questionnaire (MGH-SFQ) to assess sexual desire in 24 volunteers, ages 18 to 50

Han Y, Li Y, He B

This effect is part of the entero-insular axis of glucose homeostasis and is estimated to be responsible for at least 50% of insulin secretion [2, 3]

That would be a catastrophic overdose
